News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.
20 hrs ago | AmericanBankingNews.com
Shares of GlaxoSmithKline plc traded down 0.04% on Friday, hitting $47.68. 2,687,318 shares of the company's stock traded hands.
Yesterday | ETaiwanNews.com
Under the settlement announced Wednesday, the London-based pharmaceutical also agreed to rules that bar it from paying doctors to promote its products; providing financial incentives that encourage salespeople to market s using results from inadequate studies or making unapproved claims that a product was "better, more effective, safer or has less ... (more)
Theravance is probably a familiar name to many of you. The pharmaceutical company has received extensive coverage on Seeking Alpha over the years.
Essynce Boswell, 5, slides down an inflatable slide during the 15th annual Durham Rescue Mission back-to-school party on Thursday, August 21, 2014.
The GlaxoSmithKline PLC corruption matter in China continues to reverberate throughout the international business community, inside and outside China.
With shares of Amgen trading at near 52-week highs, investors are getting nervous about the next couple of quarters.
It's been a bad few months for GlaxoSmithKline , the British based company with North American headquarters in Research Triangle Park.
Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects.
POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline's rights to TreximetA have been acquired by Pernix Therapeutics Holdings, Inc. .
GlaxoSmithKline plc today announced that the FDA has approved Arnuitya ElliptaA , a once-daily inhaled corticosteroid medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older.
But is this merely a buying opportunity for a solid company? It trades as one of the cheapest pharma companies around and offers one of the best dividend yields.
U.S. generic drugs company Mylan Inc., private equity groups TPG Capital LLP, Advent International, KKR & Co L.P., and Warburg Pincus LLC, and some Indian drug makers have made it through to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline PLC, according to people familiar with the sales process.
Dividends: They're the cornerstone to any healthy, long-term-focused portfolio. But when it comes to the health care industry, securing dividend income isn't as easy as it sounds.
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Sanford-Burnham Medical Research Institute on Aug. 19 announced it has selected Dr. Perry Nisen as CEO at its La Jolla, Calif.-based headquarters.
Updated: Fri Aug 22, 2014 04:05 pm
Copyright © 2014 Topix LLC